Inventor · disambiguated record
Yaping Yang
Also filed as: YANG YAPING
9 granted patents·5 pending applications·11 citations·filing 2015–2025
80Inventor score
Files withBEIJING HANMI PHARMACEUTICAL CO LTD9Beijing hanmi pharm co ltd3FUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD2
Top patents by PatentIndex Score
14 records- 0182US11319378B2Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the sameBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 3, 2022·3 cites·9 claims
- 0277US11498977B2Heterodimeric immunoglobulin constructs and preparation methods thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 15, 2022·2 cites·37 claims
- 0375US11072651B2Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibodyBeijing hanmi pharm co ltd·Filed 2017·Granted Jul 27, 2021·2 cites·17 claims
- 0474US11117967B2Antibody specifically binding to PD-1 and functional fragment thereofBeijing hanmi pharm co ltd·Filed 2017·Granted Sep 14, 2021·2 cites·37 claims
- 0573US11753471B2Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing sameBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 12, 2023·1 cites·9 claims
- 0669US11827697B2Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 28, 2023·1 cites·24 claims
- 0755US2025376533A1Anti-cd40 antibody, anti-pd-l1×cd40 bispecific antibody, and use thereofFUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 0854US2024034801A1Anti-pd-l1/anti-4-1bb natural antibody structure-like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0954US2024052037A1Anti-pd-l1/anti-cd47 natural antibody structure-like heterodimeric form bispecific antibody and preparation thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1046US11739151B2Anti-PD-L1/anti-CD47 bispecific antibodyBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 29, 2023·0 cites·18 claims
- 1145US12325743B2Anti-TNFα/anti IL-17A natural antibody structure-like heterodimer form of bispecific antibody and preparation method thereforBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 10, 2025·0 cites·23 claims
- 1244US11591409B2Anti-PD-L1/anti-PD-1 natural antibody structure-like heterodimeric bispecific antibody and preparation thereofBeijing hanmi pharm co ltd·Filed 2018·Granted Feb 28, 2023·0 cites·8 claims
- 1342US2025313644A1Antibodies capable of specifically binding tl1a and use thereofFUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD·Filed 2025·Application pending·0 cites
- 1432US2016340422A1Bifunctional fusion protein, preparation method therefor, and use thereofBEIJING HANMI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yaping Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →